Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Grebely, G. Dore, Sébastien Morin, J. Rockstroh, M. Klein (2017)
Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?Journal of the International AIDS Society, 20
J. Doyle, N. Scott, R. Sacks-Davis, A. Pedrana, A. Thompson, M. Hellard (2019)
Treatment access is only the first step to hepatitis C elimination: experience of universal anti‐viral treatment access in AustraliaAlimentary Pharmacology & Therapeutics, 49
A. Litwin, M. Drolet, C. Nwankwo, M. Torrens, A. Kastelic, S. Walcher, L. Somaini, E. Mulvihill, J. Ertl, J. Grebely (2019)
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE StudyJournal of Viral Hepatitis, 26
A. Thompson (2016)
Australian recommendations for the management of hepatitis C virus infection: a consensus statementMedical Journal of Australia, 204
Ena Oru, A. Trickey, R. Shirali, S. Kanters, P. Easterbrook (2021)
Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysisThe Lancet. Global Health, 9
L. Morris, L. Selvey, O. Williams, C. Gilks, Amanda Kvassy, A. Smirnov (2020)
Hepatitis C cascade of care at an integrated community facility for people who inject drugs.Journal of substance abuse treatment, 114
B. Harney, Rebecca Brereton, B. Whitton, Danusia Pietrzak, E. Paige, S. Roberts, Susanne Birks, Sudeep Saraf, M. Hellard, J. Doyle (2021)
Hepatitis C treatment in a co‐located mental health and alcohol and drug service using a nurse‐led model of careJournal of Viral Hepatitis, 28
Michael Manns, Heiner Wedemeyer, M. Cornberg (2006)
Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 55
Anna Palmer, Kico Chan, J. Gold, C. Layton, Imogen Elsum, M. Hellard, M. Stoové, J. Doyle, A. Pedrana, N. Scott (2021)
A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community‐based testing campaignJournal of Viral Hepatitis, 28
(2017)
Risk of hepatocellular cancer in HCV patients treated with directacting antiviral agents. Gastroenterology
(1997)
Side effects of alpha interferon in chronic hepatitis
M. Traeger, A. Pedrana, D. Santen, J. Doyle, J. Howell, A. Thompson, C. El-Hayek, J. Asselin, Victoria Polkinghorne, Dean Membrey, Frances Bramwell, A. Carter, R. Guy, M. Stoové, M. Hellard (2020)
The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health servicesPLoS ONE, 15
E. Cunningham, B. Hajarizadeh, J. Amin, A. Litwin, E. Gane, C. Cooper, K. Lacombe, M. Hellard, P. Read, J. Powis, O. Dalgard, J. Bruneau, G. Matthews, J. Feld, J. Dillon, D. Shaw, P. Bruggmann, B. Conway, C. Fraser, P. Marks, G. Dore, J. Grebely, J. Grebely, G. Dore, O. Dalgard, P. Bruggmann, C. Stedman, K. Lacombe, J. Powis, M. Hellard, Sione Crawford, T. Swan, J. Byrne, M. Lacalamita, E. Cunningham, B. Hajarizadeh, P. Marks, I. Shaw, Sharmila Siriragavan, J. Amin, Sophie Quiene, K. Petoumenos, P. Schmid, E. Castro, A. Moriggia, J. Daulouède, B. Conway, C. Fraser, J. Feld, J. Bruneau, C. Cooper, E. Gane, G. Matthews, A. Dunlop, I. Kronborg, D. Shaw, A. Litwin, M. Thurnheer, M. Weltman, P. Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, P. Messina, Marzia Pantic, M. Cam, Cecilia Maitre, J. Andreassen, Ingunn Melkeraaen, M. Tollefsen, Hannah Pagarigan, R. Milne, K. Mason, D. Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, J. Milloy, Victoria Oliver, Theresa Noonan, Alison Sevehon, S. Hazelwood, Michelle Hall, M. Hagenauer, R. Liddle, Catherine Ferguson, L. Agyemang, Hiral Patel, I. Soloway, O. Cerocchi, V. Fragomeli, R. Gilliver, R. Lothian, S. Cleary, L. Johnston, Sarah Middleton, D. Brainard, J. McHutchison (2019)
Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
F. Kanwal, J. Kramer, S. Asch, M. Chayanupatkul, Yumei Cao, H. El‐Serag (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.Gastroenterology, 153 4
I. Gamkrelidze, J. Pawlotsky, J. Lazarus, J. Feld, S. Zeuzem, Y. Bao, Ana Santos, Y. Gonzalez, H. Razavi (2021)
Progress towards hepatitis C virus elimination in high‐income countries: An updated analysisLiver International, 41
M. Alavi, H. Poustchi, S. Merat, Soudeh Kaveh-Ei, A. Rahimi-Movaghar, Behrang Shadloo, B. Hajarizadeh, J. Grebely, G. Dore, R. Malekzadeh (2019)
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study.The International journal on drug policy
(2020)
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialistsThe practitioner experience
N. Afdhal, S. Zeuzem, P. Kwo, M. Chojkier, N. Gitlin, M. Puoti, M. Romero‐Gomez, J. Zarski, K. Agarwal, P. Buggisch, G. Foster, N. Bräu, M. Buti, I. Jacobson, G. Subramanian, Xiao Ding, H. Mo, Jenny Yang, P. Pang, W. Symonds, J. McHutchison, A. Muir, A. Mangia, P. Marcellin (2014)
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.The New England journal of medicine, 370 20
L. Brener, William Hippel, C. Hippel, I. Resnick, C. Treloar (2010)
Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach.Drug and alcohol review, 29 5
W. Eddings, Yulia Marchenko (2012)
Diagnostics for Multiple Imputation in StataThe Stata Journal, 12
A. Wade, J. Doyle, E. Gane, C. Stedman, B. Draper, D. Iser, S. Roberts, W. Kemp, D. Petrie, N. Scott, P. Higgs, P. Agius, J. Roney, L. Stothers, A. Thompson, M. Hellard (2020)
Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
M. Beiser, Kamala Smith, Molly Ingemi, E. Mulligan, Travis Baggett (2019)
Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.The International journal on drug policy
(2018)
Directacting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and metaanalysis
Yang Liu, A. De (2015)
Multiple Imputation by Fully Conditional Specification for Dealing with Missing Data in a Large Epidemiologic StudyInternational journal of statistics in medical research, 4
L. Degenhardt, A. Peacock, Samantha Colledge, J. Leung, J. Grebely, P. Vickerman, J. Stone, E. Cunningham, A. Trickey, Kostyantyn Dumchev, M. Lynskey, P. Griffiths, R. Mattick, M. Hickman, S. Larney (2017)
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewThe Lancet. Global Health, 5
M. O’Sullivan, Anna-Marie Jones, H. Gage, Jake Jordan, Ekelechi MacPepple, H. Williams, S. Verma (2020)
ITTREAT (Integrated Community Test ‐ Stage ‐ TREAT) Hepatitis C service for people who use drugs: Real‐world outcomesLiver International, 40
J. Pawlotsky, F. Negro, A. Aghemo, M. Berenguer, O. Dalgard, G. Dusheiko, F. Marra, M. Puoti, H. Wedemeyer (2020)
EASL recommendations on treatment of hepatitis C - Final update of the series.Journal of hepatology
S. Bajis, J. Grebely, Lucy Cooper, Julie Smith, G. Owen, Alan Chudleigh, B. Hajarizadeh, M. Martinello, S. Adey, P. Read, R. Gilliver, T. Applegate, C. Treloar, L. Maher, G. Dore (2019)
Hepatitis C virus testing, liver disease assessment and direct‐acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness studyJournal of Viral Hepatitis, 26
A. Amoako, David Ortiz-Paredes, K. Engler, B. Lebouché, M. Klein (2021)
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis.The International journal on drug policy
(1997)
Side effects of alpha interferon in chronic hepatitis C
Kico Chan, Imogen Elsum, J. Gold, C. Layton, L. Accadia, M. Bryant, J. Gunn, Filip Djordjevic, Isabelle Purcell, Jane Dicka, M. Forrest, Sione Crawford, M. Hellard, A. Pedrana (2020)
Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, AustraliaJournal of Viral Hepatitis, 28
Anna Palmer, A. Wade, B. Draper, J. Howell, J. Doyle, D. Petrie, A. Thompson, David Wilson, M. Hellard, N. Scott (2019)
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment.The International journal on drug policy, 76
H. Valerio, M. Alavi, D. Silk, C. Treloar, M. Martinello, A. Milat, A. Dunlop, J. Holden, C. Henderson, J. Amin, P. Read, P. Marks, L. Degenhardt, J. Hayllar, D. Reid, C. Gorton, T. Lam, G. Dore, J. Grebely (2020)
Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
B. Harney, B. Whitton, Cheryll Lim, E. Paige, Belinda McDonald, Sarah Nolan, D. Pemberton, M. Hellard, Josephine Doyle (2019)
Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia.The International journal on drug policy
B. Williams, J. Howell, J. Doyle, A. Thompson, B. Draper, C. Layton, N. Latham, Frances Bramwell, Dean Membrey, M. Mcpherson, J. Roney, M. Stoové, M. Hellard, A. Pedrana (2019)
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.The International journal on drug policy
Brandon Muncan, S. Walters, Jerel Ezell, D. Ompad (2020)
“They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York CityHarm Reduction Journal, 17
A. Wade, D. MacDonald, J. Doyle, A. Gordon, S. Roberts, A. Thompson, M. Hellard (2015)
The Cascade of Care for an Australian Community-Based Hepatitis C Treatment ServicePLoS ONE, 10
Liver International – Wiley
Published: Mar 1, 2022
Keywords: hepatitis C; injection drug use; nurses; primary care
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.